Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-06-28 @ 3:29 AM
Study NCT ID:
NCT01116193
Status:
COMPLETED
Last Update Posted:
2017-09-14
First Post:
2010-04-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Sponsor:
Institut de Cancérologie de la Loire
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2009-01b
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |